LAXAF — Laxai Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.46m
Annual balance sheet for Laxai Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.699 | 0.361 | 0.001 | 0.004 | 0.002 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.01 | 4.29 | 0.402 | 0 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.76 | 7.67 | 0.403 | 0.004 | 0.002 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.6 | 2.2 | 0.005 | 0.005 | 0.005 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12.4 | 14.1 | 0.574 | 0.093 | 0.007 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.56 | 5.05 | 0.65 | 1.04 | 1.35 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.58 | 6.78 | 0.65 | 1.04 | 1.35 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.79 | 7.32 | -0.076 | -0.944 | -1.35 |
| Total Liabilities & Shareholders' Equity | 12.4 | 14.1 | 0.574 | 0.093 | 0.007 |
| Total Common Shares Outstanding |